Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.
Das A, Henderson F Jr, Lowe S, Wallace GC 4th, Vandergrift WA 3rd, Lindhorst SM, Varma AK, Infinger LK, Giglio P, Banik NL, Patel SJ, Cachia D.
Das A, et al. Among authors: cachia d.
Cancer Chemother Pharmacol. 2018 Dec;82(6):945-952. doi: 10.1007/s00280-018-3684-7. Epub 2018 Sep 12.
Cancer Chemother Pharmacol. 2018.
PMID: 30209569